Post-earnings recap
Reported
Mon, Nov 15, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
38%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Immunome Inc's earnings report showed a loss per share of $0.65, with no revenue figures disclosed. The stock reacted negatively, declining by 1.93%. The lack of guidance and specific revenue details may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.65 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding the financial outlook. They emphasized the importance of their ongoing projects and research.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The focus remains on advancing their pipeline despite the current financial results.